Arbutus Biopharma (ABUS) Acquisitions (2015)
Arbutus Biopharma (ABUS) posted quarterly Acquisitions of $324000.0 for Q1 2015.
Arbutus Biopharma (ABUS) Acquisitions (2015) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Acquisitions for 1 consecutive years, with $324000.0 the latest figure, recorded in Q1 2015.
- Quarterly Acquisitions changed N/A year-over-year to $324000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $324000.0 (changed N/A YoY) and the FY2015 annual result came in at $324000.0, changed N/A from the prior year.
- Acquisitions held at $324000.0 in Q1 2015 per ABUS's latest filing.
- Over the last five years, Acquisitions for ABUS reached as high as $324000.0 in Q1 2015 and fell as low as $324000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 324,000.00 |